Literature DB >> 25878481

Oral mucocutaneous lesions - a comparative clinicopathological and immunofluorescence study.

Annasamy Rameshkumar1, Alex Kumaranthara Varghese2, Thayalan Dineshkumar3, Shaheen Ahmed4, Janaki Venkatramani5, G Sugirtharaj6.   

Abstract

BACKGROUND: Oral mucosa is often affected by many diseases including mucocutaneous disorders. The diagnoses of these disorders are primarily based on history, clinical features, and histopathology. For the past few years' immunofluorescence techniques emerged as an important tool to study the pathogenesis and in the diagnosis of oral mucocutaneous and vesiculobullous disorders. The present study was designed to carry out retrospective and prospective analysis of oral mucocutaneous lesions to elucidate the clinicopathologic features and its immunofluorescence findings.
MATERIALS AND METHODS: A total of 70 subjects with oral mucocutaneous lesions were retrieved from the oral pathology files of Tamil Nadu Govt. Dental College and their clinical features were evaluated, and the histopathology was also evaluated with the help of hematoxylin and eosin stained sections. For the prospective study, biopsy from 12 subjects with oral mucocutaneous lesions was subjected to routine histopathological examination and DIF to evaluate the consistency of the methods.
RESULTS: In the retrospective analysis of 70 subjects with oral mucocutaneous lesions in relation to clinical features and histopathology, most of the findings were similar to the previous studies except for few criteria like male predilection in lichen planus and mucous membrane pemphigoid (MMP) and more prevalence of pemphigus vulgaris than MMP (2:1). In the prospective analysis of 12 subjects, the histopathological diagnosis was consistent with DIF study in 66% of cases.
CONCLUSION: The diagnostic efficiency of oral mucocutaneous lesions can be improved by modern tools like DIF studies in addition to traditional methods like clinical and histopathology.

Entities:  

Keywords:  Histopathology; immunofluorescence; mucocutaneous lesions; oral

Year:  2015        PMID: 25878481      PMCID: PMC4385728     

Source DB:  PubMed          Journal:  J Int Oral Health        ISSN: 0976-1799


Introduction

Oral mucosa is often affected by many diseases including mucocutaneous disorders. The diagnoses of these disorders are primarily based on history, clinical features, and histopathology. The oral mucocutaneous lesions cause diagnostic problems, as these lesions resemble each other, and routine tissue biopsies may only offer a diagnosis of non-specific inflammation.1 For the past few years, immunofluorescence techniques emerged as an important tool in detecting the pathogenesis and diagnosis of oral mucocutaneous lesions (and vesiculobullous disorders). Two types of immunofluorescence techniques that commonly followed are direct immunofluorescence (DIF) and indirect immunofluorescence (IIF). In some diseases, IIF studies have revealed circulating autoantibodies2,3 whereas DIF studies have revealed immunoglobulins, complement components and other protein substances within the affected tissue.4 These circulating and tissue-bound substances may have a role in the immunopathogenesis of these diseases. In addition detection of these immune reactive substances by DIF aids in the diagnosis of many skin and mucosal diseases.1 The presence of characteristic fluorescent patterns in DIF can definitely establish the diagnosis of pemphigus and pemphigoid and strongly indicate the likelihood of lichen planus (LP) and lupus erythematosus. The absence of these fluorescent patterns rules out these conditions, thereby strengthening the diagnosis of other oral mucosal diseases. The results of DIF are sufficiently useful in the diagnosis of chronic ulcerative diseases of the oral mucosa.1 Based on these facts, a prospective study of oral mucocutaneous lesions was designed to evaluate the consistency of the histopathology with DIF. A retrospective analysis of the prevalence of oral mucocutaneous lesions namely oral LP (OLP), discoid lupus erythematosus (DLE), pemphigus vulgaris (PV), and mucous membrane pemphigoid (MMP) were also studied with regards to demographic details and histopathological features (hematoxylin and eosin stained sections) that are characteristic of each disease were evaluated.

Materials and Methods

Twenty consecutive subjects in each of OLP, DLE, PV, and ten consecutive subject of MMP (total 70 subjects) were retrieved from the oral pathology files of Tamil Nadu Govt. Dental College and reviewed for salient features including age, gender, and intraoral site of the lesion. Hematoxylin and eosin (H and E) stained sections of all the 70 subjects were reviewed, and the histopathological patterns were evaluated (retrospective study). Twelve subjects with chronic or recurrent ulcerative or erosive or vesiculobullous diseases of the oral mucosa were included for the prospective study. Biopsy specimens were taken from the perilesional area in all the 12 subjects. Specimens were examined by routine histopathological methods (H and E) and DIF. Specimens for DIF study were quickly washed in normal saline and stored immediately in Michel’s media and transported to the laboratory.

Results

Retrospective evaluation

The retrospective study comprised of 70 subjects - 20 subjects in each of OLP, DLE, and PV and 10 subjects of MMP. The following significant results were derived (Table 1).
Table 1

Retrospective analysis showing the demographic and histopathological details.

Retrospective analysis showing the demographic and histopathological details.

OLP

Eleven males affected against 9 females (1:0:81). Fifth decade was predominantly involved - 30% (6 subjects). Youngest involved was 11 years, and oldest was 72 years, mean age - 42.05 years. Buccal mucosa was involved in 85% of the subject. Histopathologically, basal cell degeneration and subepithelial band of chronic inflammatory cells were seen in 100% of subjects.

PV

Seven males affected against 13 females, sixth decade was predominantly involved - 45% (9 subjects). Youngest individual was 33 years, and oldest was 78 years mean age - 52 years. Buccal mucosa was involved in 60% of subjects. Histopathologically, epithelium ulcerated in 40% of subjects, intact basal cells attached to connective tissue seen in 100% of subjects, acantholytic (Tzanck) cells seen in 85% of subjects and dense chronic inflammatory cells seen in the connective tissue in 55% subjects.

MMP

Seven males affected against 3 females (1:0.42) fifth and sixth decades were predominantly involved - 60% (6 subjects). Youngest individual was 33 years, and oldest was 70 years, mean age - 48 years. Gingiva was involved in 60% of subjects. Nikolsky’s sign positive in 40% of subjects. Histopathologically, subepithelial split was seen in 100% of the subjects, 40% showed inflammatory cells and red blood cells in the split, diffuse chronic inflammatory cells seen in the connective tissue in 90% of subjects and increased vascularity seen in 50% of subjects.

DLE

Five males affected against 15 females (1:3), third and fourth decades were predominantly involved - 45% (9 subjects). Youngest individual was 17 years, and oldest was 70 years mean age - 42 years. Lip was involved in 85% of subjects. Histopathologically, basal cell degeneration was seen in 80% and perivascular chronic inflammatory cells in 85% of subjects.

Prospective evaluation

12 cases of oral mucocutaneous lesions were subjected to routine histopathological and DIF analysis. Histopathology showed 3 cases of LP, 4 cases of MMP and 5 cases were diagnosed as non-specific chronic inflammatory lesions. In DIF study - 5 subjects were negative. 3 were reported as OLP (Figure 1), 2 were interpreted as PV (Figure 2) and 1 each of MMP (Figure 3) and LP pemphigoides (Figure 4). Histopathological diagnosis consistent with DIF in 8 cases (66%) (3 OLP, 1 MMP and 4 non-specific inflammation).
Figure 1

(Lichen planus), (a) Hyperkeratosis, basal cell degeneration of epithelium along with subepithelial band of chronic inflammatory cells (H and E, ×10), (b) direct immunofluorescence showing fibrin deposition along the basement membrane zone.

Figure 2

(Pemphigus vulgaris) (a) Supra basal cleft with Tzanck cells and intact basal layer (H and E, ×40), (b) direct immunofluorescence showing intercellular space deposition of immunoglobulin G in the epithelium.

Figure 3

(Mucous membrane pemphigoid) (a) Subepithelial cleft between epithelium and connective tissue (H and E, ×10), (b) direct immunofluorescence showing smooth, linear, and continuous band of C3 deposit along the basement membrane zone.

Figure 4

(Lichen planus pemphigoides) direct immunofluorescence showing linear deposit of C3 along the basement membrane zone.

(Lichen planus), (a) Hyperkeratosis, basal cell degeneration of epithelium along with subepithelial band of chronic inflammatory cells (H and E, ×10), (b) direct immunofluorescence showing fibrin deposition along the basement membrane zone. (Pemphigus vulgaris) (a) Supra basal cleft with Tzanck cells and intact basal layer (H and E, ×40), (b) direct immunofluorescence showing intercellular space deposition of immunoglobulin G in the epithelium. (Mucous membrane pemphigoid) (a) Subepithelial cleft between epithelium and connective tissue (H and E, ×10), (b) direct immunofluorescence showing smooth, linear, and continuous band of C3 deposit along the basement membrane zone. (Lichen planus pemphigoides) direct immunofluorescence showing linear deposit of C3 along the basement membrane zone. The histopathological diagnosis and DIF study were not consistent in four subjects in which one case diagnosed histopathologically as non-specific chronic inflammatory lesion showed positivity for LP pemphigoides in DIF. Among the other three cases, one diagnosed histopathologically as MMP was negative in DIF and two cases which were diagnosed as MMP histopathologically were found to show positivity for PV in DIF (Table 2).
Table 2

Prospective analysis showing the histopathological correlation with the immunofluorescence findings.

Prospective analysis showing the histopathological correlation with the immunofluorescence findings.

Discussion

Mucocutaneous disorders (LP, DLE, PV, and MMP) usually present themselves as chronic recurring ulcerations or vesiculobullous lesions, causing patients to seek diagnosis and treatment. Though histopathology remains the gold standard for the diagnosis, in the past few year immunofluorescent techniques emerged as a valuable tool in the diagnosis of ulcerative and vesiculobullous – mucocutaneous disorders.1 LP is predominantly a disease of the middle-aged and elderly with age ranging between 30 and 70 years.5 In the present study also, 65% of the patients were in the same age groups. LP affects both the sexes, although occasionally some survey have suggested a male predominance, majority suggested a female predilection.6,7 The slight male predilection in the present study (M: F=1:0.81) may be due to the small sample size. Similar to the most of the studies in the literature,5 the present study also showed buccal mucosal predominance. Similar to most of the studies,6 histopathology of the present study also showed hyperorthokeratosis, basal all degeneration, and subepithelial band of chronic inflammatory cells in 60%, 100%, and 100% of the subjects, respectively. DLE is a disease commonly seen in the third and fourth decades. It is also considerably more common in women than men.6,8 The present study also showed most of the subjects in the third and fourth decades (45%) with a male:female ratio of 1:3. As with the other studies,8,9 lip is the most common site of involvement in the present study (85%). A survey of literature showed that DLE lesions are characterized by hyperkeratosis, basal cell degeneration, perivasular lymphocytic infiltrate, and band like inflammatory cells in the lamina propria.10 The present study also showed basal cell degeneration, subepithelial band of chronic inflammatory cells, and perivascular chronic inflammation in 80%, 55%, and 85%, of the subjects, respectively. Epithelial atrophy alternating with hyperplasia showed a high diagnostic value for DLE against LP.10 This feature was seen in 35% subjects of the present study. PV predominantly seen between third and seventh decades and females were commonly involved. In the present study also 96% of the subjects were between third and seventh decades and female to male ratio was 1:0.53. As with the majority of the studies6,8,11 in the present study also buccal mucosa was affected in 60% of the subjects. The formation of bulla is entirely intraepithelial just above the basal layer,8 Tzanck cells and intact basal cells attached to connective tissue were seen in 80%, 85%, and 100% of the subjects, respectively. These findings were in accordance with other studies. In contrast to other studies,8,11 present study showed dense chronic inflammatory cells infiltrate in 55% of subjects. MMP usually affects older persons (fifth-eighth decade), females are commonly involved (F:M: 2:1)6 In the present study also 70% of the patients were in the age group of fifth to eighth decades. More number of males (70%) affected in the present study may be attributed to the small sample size. Gingiva is the most common site of involvement followed by buccal mucosa.8,12 In the present study also gingiva was involved in 60% of subjects and buccal mucosa was also equally involved. The sub epithelial split and diffuse chronic inflammatory cell infiltrate were seen in 100% and 90% of the subjects, this is in accordance with the previous studies.8,12 In our prospective study of 12 subjects of oral mucosal lesions by DIF, 5 were negative, 3 were LP, 2 were PV, and one each of MMP and LP pemphigoides. Histopathological diagnosis was consistent with DIF in 66% of subjects, and this was in accordance with the previous studies by Daniels and Carmen.1 Histopathological and DIF results were similar in 3 cases of OLP, and one case of MMP and 4 subjects which were found to be non-specific inflammation were also found to be negative in DIF study. Negative results in DIF will help us to rule out those diseases which produces specific fluorescent patterns and thereby strengthening the diagnosis of other oral mucosal lesions. Though in some cases histopathology is not consistent with DIF both were able to offer diagnosis in 2/3 of the subjects. Early diagnosis of MMP is important since the prevalence of concurrent eye lesions is greater with oral lesions. DIF is more specific and sensitive than histopathology and electron microscopy in diagnosing MMP.13-15 Immunofluorescence analysis is also a helpful tool in monitoring therapeutic responses of these lesions by analyzing the lesion specific autoantibodies.16

Conclusion

Although the histopathology remains the gold standard for the diagnosis of most of the diseases, it is inferred from this study that not all lesions are amenable to a definitive diagnosis. Due to the accuracy of DLF study in diagnosing diseases, its report is taken as the final diagnosis, which ascertains the course and prognosis of the disease. However, the consistency of the DLF in this study cannot be substantiated due to the limited sample size which is attributed to cost effectiveness of the DLF technique.
  12 in total

Review 1.  Contemporary issues in the diagnosis of oral pemphigoid: a selective review of the literature.

Authors:  S Dayan; R K Simmons; A R Ahmed
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1999-10

Review 2.  Immunofluorescence in dermatology.

Authors:  D F Mutasim; B B Adams
Journal:  J Am Acad Dermatol       Date:  2001-12       Impact factor: 11.527

Review 3.  Recent advances in mucous membrane pemphigoid.

Authors:  Ebenezer Daniel; Jennifer E Thorne
Journal:  Curr Opin Ophthalmol       Date:  2008-07       Impact factor: 3.761

Review 4.  Mucocutaneous features of autoimmune blistering diseases.

Authors:  M A Weinberg; M S Insler; R B Campen
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1997-11

Review 5.  The management of mucous membrane pemphigoid and pemphigus.

Authors:  Richelle M Knudson; Amer N Kalaaji; Alison J Bruce
Journal:  Dermatol Ther       Date:  2010 May-Jun       Impact factor: 2.851

Review 6.  Lichen planus: review and update on pathogenesis.

Authors:  C Scully; M el-Kom
Journal:  J Oral Pathol       Date:  1985-07

Review 7.  Mucous membrane pemphigoid: an update.

Authors:  Margherita E Eschle-Meniconi; Sumera R Ahmad; C Stephen Foster
Journal:  Curr Opin Ophthalmol       Date:  2005-10       Impact factor: 3.761

Review 8.  Ocular and oral mucous membrane pemphigoid (cicatricial pemphigoid).

Authors:  Lawrence S Chan
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

Review 9.  Cicatricial pemphigoid.

Authors:  T E Fleming; N J Korman
Journal:  J Am Acad Dermatol       Date:  2000-10       Impact factor: 11.527

10.  Direct immunofluorescence in oral mucosal disease: a diagnostic analysis of 130 cases.

Authors:  T E Daniels; C Quadra-White
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1981-01
View more
  3 in total

1.  Direct Immunofluorescence in Oral Lichen Planus.

Authors:  Waranun Buajeeb; Nis Okuma; Supanee Thanakun; Titikarn Laothumthut
Journal:  J Clin Diagn Res       Date:  2015-08-01

2.  Awareness about oral pathology specialty among medical professionals in hospitals under Kerala Health Services Department in Malappuram district in Kerala, India.

Authors:  Thorakkal Shamim
Journal:  J Family Med Prim Care       Date:  2019-02

3.  European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.

Authors:  E Schmidt; H Rashid; A V Marzano; A Lamberts; G Di Zenzo; G F H Diercks; S Alberti-Violetti; R J Barry; L Borradori; M Caproni; B Carey; M Carrozzo; G Cianchini; A Corrà; F G Dikkers; C Feliciani; G Geerling; G Genovese; M Hertl; P Joly; J M Meijer; V Mercadante; D F Murrell; M Ormond; H H Pas; A Patsatsi; S Rauz; B D van Rhijn; M Roth; J Setterfield; D Zillikens; G Zambruno; B Horváth; F Caux
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-26       Impact factor: 6.166

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.